Virtus Biotech Clinical Trials ETF
12 hedge funds and large institutions have $4.08M invested in Virtus Biotech Clinical Trials ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.89% more ownership
Funds ownership: 16.13% → 23.02% (+6.9%)
Holders
12
Holding in Top 10
–
Calls
$554K
Puts
–
Top Buyers
| 1 | +$758K | |
| 2 | +$535K | |
| 3 | +$237K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$83.5K |
| 5 |
Morgan Stanley
New York
|
+$52.1K |